Pharma News

Brevipil tablet

Sun Pharma launches a generic Brevipil tablet.

Sun Pharma launches generic Brevipil tablet following patent expiry of the innovator product. (1) Sun Pharmaceuticals have recently launched an anti–epileptic drug called Brevipil in the market. The company did this launch on 22 February 2021, a day after the expiry of the innovator drug’s patent. The innovator drug for this generic version is called Brivaracetam. […]

Sun Pharma launches a generic Brevipil tablet. Read More »

Recall certain medications

Lupin and Aurobindo Pharma Recall certain medications

Lupin and Aurobindo Pharma initiates nationwide recall of certain medications in the US market: The latest enforcement report of the USFDA[1] has led to the recall of certain medications by two major pharma companies. The companies involved are Lupin and Aurobindo Pharma. These drug firms are recalling some of their products from the American market.

Lupin and Aurobindo Pharma Recall certain medications Read More »

Pharma News – 20 February

Pharma News – 20 February 2021 (Updates)

Lupin and Aurobindo Pharma initiates nationwide recall Pharma News – 20 February: The latest enforcement report of the USFDA[1] has led to the recall of certain medications by two major pharma companies. The companies involved are Lupin and Aurobindo Pharma. Baltimore – based unit of Lupin Pharmaceuticals Inc. has been actively recalling an antiviral medication.

Pharma News – 20 February 2021 (Updates) Read More »

The technology of covid vaccine under review

Covid-19 vaccines manufactured by two pharma companiesare put on hold over certain pressing matters (technology of covid vaccine). Inovio Pharmaceuticals Inovio Pharmaceuticals has been actively working on a DNA-based Covid-19 vaccine to trigger humans’ immune response. This company is already conducting phase-1 trials for this vaccine and is expected to step up into the next

The technology of covid vaccine under review Read More »

Scroll to Top